Viewing Study NCT03805594


Ignite Creation Date: 2025-12-25 @ 1:31 AM
Ignite Modification Date: 2025-12-31 @ 7:25 PM
Study NCT ID: NCT03805594
Status: COMPLETED
Last Update Posted: 2025-02-25
First Post: 2019-01-09
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: 177Lu-PSMA-617 and Pembrolizumab in Treating Patients With Metastatic Castration-Resistant Prostate Cancer
Sponsor: University of California, San Francisco
Organization: